RT Journal
T1 Direct-to-consumer offers for free and discounted medications on the internet: A content analysis of “e-samples”
JF Archives of Internal Medicine
JO Archives of Internal Medicine
YR 2009
FD November 23
VO 169
IS 21
SP 2024
OP 2030
DO 10.1001/archinternmed.2009.397
UL http://dx.doi.org/10.1001/archinternmed.2009.397
AB 
The United States has witnessed dramatic changes in the marketing of prescription drugs over the past decade. From one perspective, patients, exposed to a dramatic increase in direct-to-consumer (DTC) promotion of prescription medications,1 are now “consumers” of health care. The pharmaceutical industry suggests that this promotion helps patients make more informed choices.2 However, observers have questioned the benefits of DTC marketing and the balance of associated risk and benefit information.3- 4